Furthermore, our research group published a work showing high expression of SIRT-3 in HCC patients with type-2 diabetes mellitus (T2DM) and in those undergoing chronic treatment with metformin [4]. The gene discussed is SIRT3; the disease is hepatocellular carcinoma.